da Vinci Heads to China

Recs

9

Following in the footsteps of The Motley Fool's Bill Mann, Rule Breakers pick Intuitive Surgical's (Nasdaq: ISRG) da Vinci surgical system is headed off to China.

Last week, Chindex (Nasdaq: CHDX) announced that China's version of the FDA had given the green light for the company to sell the da Vinci in China, as well as Candela's (Nasdaq: CLZR) AlexLaser system. Chindex has been selling the da Vinci in Hong Kong since 2005, so it does have some experience hocking the robotic surgical system.

Foreign sales have become an important part of Intuitive Surgical's growth story. Last quarter, sales to foreign hospitals accounted for 27% of surgical systems sales, up slightly from the first quarter of 2007. All those sales of da Vinci systems aren't just one-time sales for the company. The installed base drives sales of high-margin disposable supplies to run the systems, so having the opportunity to sell systems to more hospitals is a driver of revenue growth in both the short and long term.

It could take a while for sales of da Vinci systems in China to pick up, since -- as in the U.S. -- the hospitals will have to work the major purchase into their budgets. When the sales do finally pick up, the average selling price may slip a little, but investors shouldn't be alarmed. Having a middleman sell the systems means that Intuitive Surgical will likely have to discount the systems sold to Chindex, but it'll make up for it in operating margin, since Intuitive Surgical won't have to pay a sales force.

With a P/E still north of 60, Intuitive Surgical isn't cheap by the standards of other medical device makers like Medtronic (NYSE: MDT) or Stryker (NYSE: SYK), but those companies just don't have the growth potential of Intuitive Surgical. Now that it has an additional 1.3 billion people to market the da Vinci to, Intuitive Surgical's growth story may just be getting started.

More slicing and dicing ahead:

Like this article? Get our best articles delivered direct to your inbox at no cost. Sign up for Foolwatch Weekly by entering your email below.

Find out why Intuitive Surgical has been recommended three times by the Motley Fool Rule Breakers newsletter. Click here to grab a free 30-day trial subscription and get the latest issue, as well as access to the archives.

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. The Fool has a disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 679615, ~/Articles/ArticleHandler.aspx, 11/21/2009 8:49:32 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
An Open Letter to the Federal Reserve

Related Tickers

11/20/2009 4:00 PM
MDT $39.62 Up +0.01 +0.03%
Medtronic, Inc. CAPS Rating: ****
SYK $48.73 Down -0.09 -0.18%
Stryker Corp CAPS Rating: *****
CHDX $14.43 Down -0.66 -4.37%
Chindex Internatio… CAPS Rating: ***
CLZR $2.89 Down -0.06 -2.03%
Candela Corp CAPS Rating: *
ISRG $276.44 Down -2.24 -0.80%
Intuitive Surgical… CAPS Rating: ****

Community: Investing Wiki

Term Of The Hour

Oligopoly: In economics, an oligopoly is a market type in which a few (more than one, usually less than five) firms compete.

Want to learn more or edit this definition?
Click here to read more!